These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27171020)

  • 21. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil.
    Hsu CY; Shen YC; Yu CW; Hsu C; Hu FC; Hsu CH; Chen BB; Wei SY; Cheng AL; Shih TT
    J Hepatol; 2011 Oct; 55(4):858-65. PubMed ID: 21338641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Hepatocellular Carcinoma Response to
    Hectors SJ; Lewis S; Kennedy P; Bane O; Said D; Segall M; Schwartz M; Kim E; Taouli B
    Radiol Imaging Cancer; 2020 Jul; 2(4):e190094. PubMed ID: 32803165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
    Ishigami K; Yoshimitsu K; Nishihara Y; Irie H; Asayama Y; Tajima T; Nishie A; Hirakawa M; Ushijima Y; Okamoto D; Taketomi A; Honda H
    Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.
    Corona-Villalobos CP; Halappa VG; Bonekamp S; Eng J; Reyes D; Cosgrove D; Rastegar N; Pan L; Pawlik TM; Kamel IR
    Invest Radiol; 2015 Apr; 50(4):283-9. PubMed ID: 25396692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
    Lee DH; Lee JM; Klotz E; Han JK
    Invest Radiol; 2016 Jul; 51(7):430-4. PubMed ID: 26756941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma after systemic chemotherapy: gadolinium-enhanced mr measurement of necrosis by volume histogram.
    Jeong YY; Mitchell DG; Hann HW; Malin AK; Kang HK; Holland GA; Capizzi RL
    J Comput Assist Tomogr; 2001; 25(4):624-8. PubMed ID: 11473196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
    Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative dynamic contrast-enhanced ultrasound may help predict the outcome of hepatocellular carcinoma after microwave ablation.
    Zhan Y; Zhou F; Yu X; Luo F; Liu F; Liang P; Cheng Z; Han Z; Yu J
    Int J Hyperthermia; 2019 Jan; 35(1):105-111. PubMed ID: 30300039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response stratification and survival analysis of hepatocellular carcinoma patients treated with intra-arterial therapy using MR imaging-based arterial enhancement fraction.
    Bonekamp S; Bonekamp D; Geschwind JF; Corona-Villalobos CP; Reyes DK; Pawlik TM; Kamel IR
    J Magn Reson Imaging; 2014 Nov; 40(5):1103-11. PubMed ID: 24214827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
    Kim TK; Lee KH; Jang HJ; Haider MA; Jacks LM; Menezes RJ; Park SH; Yazdi L; Sherman M; Khalili K
    Radiology; 2011 Jun; 259(3):730-8. PubMed ID: 21364083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
    Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
    Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
    Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
    Choi JW; Lee JM; Kim SJ; Yoon JH; Baek JH; Han JK; Choi BI
    Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging.
    Yoon SH; Park CM; Park SJ; Yoon JH; Hahn S; Goo JM
    Radiology; 2016 Sep; 280(3):940-8. PubMed ID: 27031994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound.
    Zocco MA; Garcovich M; Lupascu A; Di Stasio E; Roccarina D; Annicchiarico BE; Riccardi L; Ainora ME; Ponziani F; Caracciolo G; Rapaccini GL; Landolfi R; Siciliano M; Pompili M; Gasbarrini A
    J Hepatol; 2013 Nov; 59(5):1014-21. PubMed ID: 23811306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.